The final, formatted version of the article will be published soon.
PERSPECTIVE article
Front. Pain Res.
Sec. Pharmacological Treatment of Pain
Volume 5 - 2024 |
doi: 10.3389/fpain.2024.1505019
This article is part of the Research Topic Neuraxial Therapeutics in Pain Management: Present and Future View all articles
A PERSPECTIVE: Neuraxial Therapeutics in Pain Management: Now and Future
Provisionally accepted- 1 Valencia University School of Medicine, Valencia, Italy
- 2 University College London, London, England, United Kingdom
- 3 Department of Anesthesiology, University Hospitals Cleveland Medical Center, Clevelend, Ohio, United States
- 4 Biomedical Engineering and Neurosurgery, University of Illinois, Chicago, Chicago, Illinois, United States
- 5 Departments of Anesthesiology and Pharmacology, University of California, San Diego, La Jolla, United States
The neuraxial delivery of drugs for the management of pain and other spinal pathologies is widely employed and is the subject of a large volume of ongoing research with several thousand papers appearing in the past 5 years alone on neuraxial delivery. Several learned texts have been recently published (1-4). A number of considerations have contributed to this widespread interest in the development of the use of neuraxial therapeutics to manage pain. In the following section, major topics relevant to spinal encoding and in the use of neuraxial therapeutics are considered by the Frontiers in Pain Research editors of the research topic: "Neuraxial Therapeutics in Pain Management: Now and Future". This paper seeks to serve as a perspective to encourage the submission of manuscripts reflecting research in this exciting area.
Keywords: neuraxial therapeutics, Pain Management, neuraxial delivery, therapeutic pain intervention, neuraxial targets, Spinal drug delivery
Received: 01 Oct 2024; Accepted: 11 Nov 2024.
Copyright: © 2024 De Andres, Dickenson, Hayek, Linninger and Yaksh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Tony L Yaksh, Departments of Anesthesiology and Pharmacology, University of California, San Diego, La Jolla, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.